Volume 48, Issue 1 pp. 43-45

Treatment of female pattern hair loss with a combination of spironolactone and minoxidil

Carlijn Hoedemaker

Carlijn Hoedemaker

Department of Dermatology, St Vincent’s Hospital, University of Melbourne, and Department of Medicine and Skin and Cancer Foundation, Melbourne, Victoria, Australia

Search for more papers by this author
Sylvia Van Egmond

Sylvia Van Egmond

Department of Dermatology, St Vincent’s Hospital, University of Melbourne, and Department of Medicine and Skin and Cancer Foundation, Melbourne, Victoria, Australia

Search for more papers by this author
Rodney Sinclair

Rodney Sinclair

Department of Dermatology, St Vincent’s Hospital, University of Melbourne, and Department of Medicine and Skin and Cancer Foundation, Melbourne, Victoria, Australia

Search for more papers by this author
First published: 11 January 2007
Citations: 19
Professor Rodney Sinclair, Department of Dermatology, St. Vincent’s Hospital, PO Box 2900, Fitzroy, Vic. 3065, Australia. Email: [email protected]

Carlijn Hoedemaker, MB BS. Sylvia van Egmond, MB BS. Rodney Sinclair, FACD.

SUMMARY

A 53-year-old woman with clinical evidence of female pattern hair loss and histological evidence of androgenetic alopecia was initially treated with the oral antiandrogen spironolactone 200 mg daily. Serial scalp photography documented hair regrowth at 12 months; however, the hair regrowth plateaued, and at 24 months there had been no further improvement in hair density. Twice daily therapy with topical minoxidil 5% solution was then introduced and further regrowth documented, confirming the additive effect of combination therapy.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.